FDA Rejection of Atara’s Rare Cancer Therapy Sparks Controversy Amid Allegations of Leadership Shift and Internal Reversal.
admin The experimental therapy for a rare blood cancer was on a seemingly clear path toward...
Health
Pharma and Biotech Industries Mount Vigorous Defense Against Trump Administration’s International Reference Pricing Models for Medicare
The pharmaceutical and biotechnology sectors are intensifying their opposition to a pair of aggressive Trump...
Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer treatments
At the heart of the dispute are promotional materials and public statements issued by J&J...
Gilead to buy Arcellx in nearly $8B deal
The acquisition marks the culmination of a highly successful three-year courtship between the two firms....
The Silent Epidemic: How ‘The Pitt’ and Real-World Advocacy are Exposing the Staggering Crisis of American Medical Debt.
In a recent and harrowing episode of the HBO Max medical drama "The Pitt," a...
ACIP meeting postponed, for reasons that are unclear
The reality of this "nicotine wellness" boom is far more complex and medically precarious. While...
FDA’s New Drug Chief Signals Scrutiny of Antidepressants and RSV Shots While Roche Plans Exit from Key Antibiotic Production.
The landscape of American pharmaceutical regulation and the global supply chain for essential medicines are...
Element Biosciences launches table-top sequencer capable of $100 genome
The most significant tremor in the oncology sector involves Grail’s Galleri blood test, a multi-cancer...
CDR-Life Appoints Dimitrios Chondros as Chief Medical Officer to Scale Next-Generation Immunotherapy Pipeline.
The appointment of Dimitrios Chondros as Chief Medical Officer marks a pivotal transition for CDR-Life,...
DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition
The legal action centers on a series of controversial "exclusionary" contract provisions that have become...
